Clinical Trials of Budoprutug in Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE) Underway;
Trial of Budoprutug in Primary Membranous Nephropathy (pMN) Expected to Initiate in the Coming Weeks
Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
Provided By GlobeNewswire – Last update: